Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Thiazolidinedione use, fluid retention, and congestive heart failure: a consensus statement from the American Heart Association and American Diabetes Association. October 7, 2003.

× No keyword cloud information.

203 in total

1. Peroxisome proliferator-activated receptor-γ agonists repress epithelial sodium channel expression in the kidney.

Authors: Emily Borsting; Vicki Pei-Chun Cheng; Chris K Glass; Volker Vallon; Robyn Cunard
Journal: Am J Physiol Renal Physiol Date: 2011-12-14

Review 2. Submaximal PPARγ activation and endothelial dysfunction: new perspectives for the management of cardiovascular disorders.

Authors: Pitchai Balakumar; Sonam Kathuria
Journal: Br J Pharmacol Date: 2012-08 Impact factor: 8.739

Review 3. Inflammation in atherosclerosis and diabetes mellitus.

Authors: Jorge Plutzky
Journal: Rev Endocr Metab Disord Date: 2004-08 Impact factor: 6.514

4. Chances and risks of SGLT2 inhibitors.

Authors: Peter Mayer
Journal: Naunyn Schmiedebergs Arch Pharmacol Date: 2011-12-24 Impact factor: 3.000

Review 5. A cardiologist's view of hypoglycemia.

Authors: Shailesh Nandish; Jamison Wyatt; Rene Oliveros; Adrienne Stevens Zion; Michael Lujan; Robert Chilton
Journal: Curr Atheroscler Rep Date: 2010-03 Impact factor: 5.113

Review 6. Updates on the management of diabetes in dialysis patients.

Authors: Connie M Rhee; Angela M Leung; Csaba P Kovesdy; Katherine E Lynch; Gregory A Brent; Kamyar Kalantar-Zadeh
Journal: Semin Dial Date: 2014-03 Impact factor: 3.455

7. Relationship between thiazolidinedione use and cardiovascular outcomes and all-cause mortality among patients with diabetes: a time-updated propensity analysis.

Authors: Zeina A Habib; Leonidas Tzogias; Suzanne L Havstad; Karen Wells; George Divine; David E Lanfear; Jeffrey Tang; Richard Krajenta; Manel Pladevall; L Keoki Williams
Journal: Pharmacoepidemiol Drug Saf Date: 2009-06 Impact factor: 2.890

Thiazolidinedione use, fluid retention, and congestive heart failure: a consensus statement from the American Heart Association and American Diabetes Association. October 7, 2003.